Company intelligence / Profile preview
Biolyse Pharma
St. Catharines, Ontario, Canada
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Biolyse Pharma manufactures and supplies approved sterile injectable chemotherapy agents including paclitaxel, docetaxel, and fluorouracil, which are used in established, guideline-supported regimens for multiple solid tumor cancers. Clinical results and efficacy of these molecules are well established through decades of clinical use; Biolyse focuses on manufacturing quality and accessibility, not novel clinical development.
- Therapeutic areas
- Oncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Biolyse Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biolyse Pharma.